NVCRNovoCure Limited

$1B

FY 2014 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$15M+49.5% YoY

Gross Profit

$5M35.2% margin

Operating Income

-$80M-517.5% margin

Net Income

-$81M-520.9% margin

EPS (Diluted)

$-1.12

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$77M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$118M

Total Liabilities

$20M

Stockholders' Equity

$98M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$10M	+49.5%
Gross Profit	$5M	$3M	+63.0%
Operating Income	-$80M	-$64M	-24.4%
Net Income	-$81M	-$77M	-4.3%

NVCR FY 2014 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena